The SARS-CoV-2/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B, Respiratory Syncytial Virus(RSV), Adenovirus and M.pneumoniae antigens in nasopharyngeal swab specimens from individuals with suspected.
Fast (15minutes)
Simple Operation (Less Training Required)
Objective (Results Read by Analyzer)
High Accuracy
| Product features | Parameters |
| Format | Cassette |
| Specimen | Nasopharyngeal Swab |
| Certificate | CE |
| Reading Time | 15 minutes |
| Storage Temperature | 2-30°C |
| Sensitivity | SARS-CoV-2: 96.4%; Influenza A+B: Type A(95.0%), Type B(92.9%); RSV: 94.3%; Adenovirus: 96.9%; M.pneumoniae: 91.8% |
| Specificity | SARS-CoV-2: 99.1%; Influenza A+B: Type A(99.1%), Type B(99.1%); RSV: 96.2%; Adenovirus: 98.6%; M.pneumoniae: 98.0% |
| Accuracy | SARS-CoV-2: 98.2%; Influenza A+B: Type A(98.4%), Type B(98.1%); RSV: 95.9%; Adenovirus: 98.4%; M.pneumoniae: 97.0% |
| Cat. No. | Product | Specimen | Pack | Cut-off |
| IRT-R555 | SARS-CoV-2/Influenza A+B/RSV/Adenovirus/M.pneumoniae Antigen Combo Rapid Test | Nasopharyngeal Swab |
